These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mechanism of demyelination in the guinea pig. Separate sensitization with encephalitogenic myelin basic protein and nonencephalitogenic brain components. Driscoll BF; Kira J; Kies MW; Alvord EC Neurochem Pathol; 1986 Feb; 4(1):11-22. PubMed ID: 2423932 [TBL] [Abstract][Full Text] [Related]
23. Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer. Teitelbaum D; Webb C; Bree M; Meshorer A; Arnon R; Sela M Clin Immunol Immunopathol; 1974 Nov; 3(2):256-62. PubMed ID: 4141659 [No Abstract] [Full Text] [Related]
24. AN ANALYSIS OF COMPONENTS OF FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG. ALVORD EC; SHAW CM; FAHLBERG WJ; KIES MW Z Immunitats Allergieforsch; 1964 Mar; 126():193-208. PubMed ID: 14185397 [No Abstract] [Full Text] [Related]
25. Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue. Bigner DD; Pitts OM; Wikstrand CJ J Neurosurg; 1981 Jul; 55(1):32-42. PubMed ID: 6165811 [No Abstract] [Full Text] [Related]
26. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)]. Lebar R; Voisin GA Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099 [No Abstract] [Full Text] [Related]
27. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant. Tanaka A Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657 [No Abstract] [Full Text] [Related]
28. Experimental allergic encephalomyelitis in the guinea pig: variation in peripheral blood lymphocyte responsiveness to myelin basic protein during disease development. Lyman WD; Kadish AS; Raine CS Cell Immunol; 1981 Sep; 63(2):409-16. PubMed ID: 6168397 [No Abstract] [Full Text] [Related]
29. Experimental allergic encephalomyelitis-inducing activity of synthetic polyadenylic and polyuridylic homopolymers and complexes in guinea pigs. Paterson PY Cell Immunol; 1976 Jan; 21(1):48-55. PubMed ID: 55310 [No Abstract] [Full Text] [Related]
30. Suppression and reversal of allergic encephalomyelitis in rhesus monkeys with basic protein and peptides. Eylar EH; Jackson JJ; Kniskern PJ Neurochem Res; 1979 Apr; 4(2):249-58. PubMed ID: 88679 [TBL] [Abstract][Full Text] [Related]
31. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant. Mitsuzawa E; Yasuda T; Tamura N; Ohtani S Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088 [TBL] [Abstract][Full Text] [Related]
32. [EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, MORPHOLOGY OF THE CENTRAL NERVOUS AND THYMICO-LYMPHATIC SYSTEMS]. RAVKINA LI Vestn Akad Med Nauk SSSR; 1963; 18():57-60. PubMed ID: 14150476 [No Abstract] [Full Text] [Related]
33. Influence of heparin and protamine on enlargement of the draining lymph node during induction of EAE. Matous-Malbohan I; Arnason BG Cell Immunol; 1974 Jun; 12(3):345-9. PubMed ID: 4142421 [No Abstract] [Full Text] [Related]
34. PSEUDOMONAS PSEUDOMALEI AND PSEUDOMONAS AERUGINOSA AS ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. LIPTON MM; STEIGMAN AJ J Immunol; 1963 Apr; 90():512-7. PubMed ID: 14082012 [No Abstract] [Full Text] [Related]
35. Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat. Goihman-Yahr M; Requena MA; Vallecalle-Suegart E; Convit J Int J Lepr Other Mycobact Dis; 1974; 42(3):266-75. PubMed ID: 4218599 [No Abstract] [Full Text] [Related]
36. Immunohistological evidence of perivascular localization of basic protein in early development of experimental allergic encephalomyelitis. Simon J; Anzil AP Acta Neuropathol; 1974 Feb; 27(1):33-42. PubMed ID: 4133213 [No Abstract] [Full Text] [Related]
37. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. Kent SJ; Karlik SJ; Cannon C; Hines DK; Yednock TA; Fritz LC; Horner HC J Neuroimmunol; 1995 Apr; 58(1):1-10. PubMed ID: 7730443 [TBL] [Abstract][Full Text] [Related]
38. Experimental allergic encephalomyelitis induced by basic protein with synthetic adjuvant in comparison with Freund's complete adjuvant. Role of antibodies in correlation with the clinicopathological features. Mitsuzawa E; Yasuda T; Tamura N; Ohtani S J Neurol Sci; 1981 Oct; 52(1):133-45. PubMed ID: 6170738 [TBL] [Abstract][Full Text] [Related]
39. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis. Lisak RP; Zweiman B Cell Immunol; 1974 Nov; 14(2):242-54. PubMed ID: 4143110 [No Abstract] [Full Text] [Related]
40. Acute allergic encephalomyelitis (EAE) in the rat with special reference to immunologic and demyelinization effects. Piliero SJ; Cremonese P J Reticuloendothel Soc; 1973 Jul; 14(1):100-18. PubMed ID: 4126715 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]